Quarterly pharmacy formulary change notice

Similar documents
Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

2018 CareOregon Advantage Part D Formulary Changes

Health Partners Medicare Prime 2019 Formulary Changes

Quarterly pharmacy formulary change notice

2019 Formulary Update

Memorial Hermann Advantage HMO February 2019 Formulary Addendum

Quarterly Pharmacy Formulary Change Notice

Quarterly pharmacy formulary change notice

AETNA BETTER HEALTH January 2017 Formulary Change(s)

Drug Name Tier Drug Name Tier

November 2018 P & T Updates

Quarterly pharmacy formulary change notice

AETNA BETTER HEALTH January 2017 Formulary Change(s)

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change

HOW TO USE THE FORMULARY

The following list of recommended PDL changes were reviewed and approved by the MHS P&T Committee on December 14 th, 2016.

Agents for Cystic Fibrosis

Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates

Changes to the 2018 BlueCross Secure SM (HMO) & BlueCross Total SM (PPO) Formularies

Quarterly Pharmacy Formulary Change Notice

Emblem Medicaid 3Q18 Formulary Updates

3 Tier Formulary Additions

Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates

These programs and quantity limitations may not apply. Check your certificate or other plan information for benefit details.

Neighborhood Medicaid Formulary Changes: June 2017

March 2017 Pharmacy & Therapeutics Committee Decisions

2018 Formulary Notice of Change Prescription Drug Plans

2018 Step Therapy (ST) Criteria

All Indiana Health Coverage Programs Pharmacy Providers

Effective for all members on August 1, 2017

Quarterly pharmacy formulary change notice

HEALTH SHARE/PROVIDENCE (OHP)

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary April 1, 2018 Updates. Formulary Alternatives

10 Musculoskeletal and Joint Diseases

Quarterly pharmacy formulary change notice

2017 Formulary Changes Year to Date

NOTIFICATION OF FORMULARY CHANGES

Oral Agents. Fml Limits. Available Strengths NF NF

WellCare Signature (PDP) and WellCare Classic (PDP) Formulary Addendum

Aetna Better Health of Illinois Medicaid Formulary Updates

FORMULARY CHANGE NOTICE 2008 JULY

Texas Prior Authorization Program Clinical Edit Criteria

Effective for all members on November 1, 2017

Cox College Springfield, MO. Dosage Calculation Competency Level II Practice Sheet STUDENT NAME: DATE: STUDENT I.D. #: ADVISOR:

Generic Name (Brand Name) Available Strengths Formulary Limits. Primidone (Mysoline) 50mg, 250mg -- $

HIV MEDICATIONS AT A GLANCE. Atripla 600/200/300 mg tablet tablet daily. Complera 200/25/300 mg tablet tablet daily

See Important Reminder at the end of this policy for important regulatory and legal information.

Network Health Insurance Corporation Upcoming Negative Changes to the Medicare Part D Formulary

Quarterly pharmacy formulary change notice

UPDATE Ohana QUEST Integration Medicaid

Provider update: Quarterly pharmacy formulary change notice

Step Therapy Requirements

September 2018 Pharmacy & Therapeutics Committee Decisions

2018 Step Therapy Criteria (List of Step Therapy Criteria)

Emblem Medicaid 4th Quarter Formulary Updates

Amerigroup Washington, Inc. to conduct postservice reviews of certain modifiers and services

2014 Quantity Limits (QL) Criteria

Aspirin. Iron Supplements

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES

Medicare Part D 2016 Formulary Changes Service To Senior and OC Preferred

Generic (Brand) Strength & Dosage form Fml Limit Cost per Rx Notes 5-HT3 Antagonists

WellCare s South Carolina Preferred Drug List Update

2017 Formulary Addendum Notice of Change

Your prescription benefit updates Formulary Updates - Effective January 1, 2019

2017 Formulary Addendum Notice of Change (Prescription Drug Plans)

Alprazolam 0.25mg, 0.5mg, 1mg tablets

San Francisco Health Plan (SFHP)

VIVA Health, Inc. Part D Cumulative Formulary Changes for 2009

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary April 1, 2018 Updates. Formulary Alternatives

Calgary Long Term Care Formulary

Drugs That Require Step Therapy (ST)

2017 Formulary Addendum Notice of Change

MEDICAID PROVIDER BULLETIN December 2017 Quarterly pharmacy formulary change notice. Effective for all patients on February 1, 2018

ADMELOG, NOVOLIN, NOVOLOG, and FIASP

2017 Formulary Addendum Notice of Change (Medicare Advantage Plans)

Drugs That Require Step Therapy (ST)

August 2016 Formulary Updates

2017 Formulary Addendum Notice of Change

Peach State Health Plan routinely reviews the medications available on the Preferred Drug

Drugs That Require Step Therapy (ST)

Drug Dosage Calculations

Pharmacy Program Updates: Quarterly Pharmacy Changes Effective July 1, 2017

MEDICAL ASSISTANCE BULLETIN

2017 Formulary Addendum Notice of Change (Medicare Advantage Plans)

Release of the 2017/18 Invitation to Tender

Health Partners Medicare Special 2018 Formulary Changes

Oral Agents. Formulary Limits. Available Strengths. IR: 4mg ER: 12mg Syrup: 2mg/5ml

Notice of Mid-Year Changes to 2019 Paramount Enhanced Formulary

Umpqua Health Alliance (OHP) Formulary Changes January 2018

Quarterly pharmacy formulary change notice

Transcription:

MEDICAID PROVIDER BULLETIN March 2019 Quarterly pharmacy formulary change notice The formulary changes listed in the table below were reviewed and approved at the fourth quarter pharmacy and therapeutics committee meeting. Effective May 1, 2019, the following formulary changes will apply. This notice applies to Anthem Blue Cross and Blue Shield Medicaid (Anthem) members enrolled in Medicaid. FACTORS LONG ACTING FACTORS LONG ACTING FACTORS - SA ERYTHROPOIETIN - (ESA) ERYTHROPOIETIN - (ESA) HIV FULPHILA 6 MG/0.6 ML SYRINGE NEULASTA 6 MG/0.6 ML SYRINGE ZARXIO 300 MCG/0.5 ML SYRINGE ZARXIO 480 MCG/0.8 ML SYRINGE PROCRIT 4;000 UNITS/ML VIAL PROCRIT 2;000 UNITS/ML VIAL PROCRIT 10;000 UNITS/ML VIAL PROCRIT 10;000 UNITS/ML VIAL PROCRIT 20;000 UNITS/ML VIAL PROCRIT 40;000 UNITS/ML VIAL PROCRIT 3;000 UNITS/ML VIAL RETACRIT 4;000 UNIT/ML VIAL RETACRIT 2;000 UNIT/ML VIAL RETACRIT 10;000 UNIT/ML VIAL RETACRIT 40;000 UNIT/ML VIAL RETACRIT 3;000 UNIT/ML VIAL COMPLERA TABLET SYMTUZA 800-150-200-10 MG TABLET ODEFSEY TABLET DELSTRIGO 100-300-300 MG TABLET WITH PRIOR AUTHORIZATION (pa) ADD QUANTITY LIMIT (QL) 2 SYRINGES PER 28 DAYS NON- WITH STEP THERAPY (ST) 12 VIALS (12 ML) PER 28 DAYS RETACRIT (PA REQUIRED) https://mediproviders.anthem.com/ky is the trade name of Anthem Kentucky Managed Care Plan, Inc., independent licensee of the Blue Cross and Blue Shield Association. ANTHEM is a registered trademark of Anthem Insurance Companies, Inc. PLEASE NOTE: Information being presented is current as of the date of publication and is subject to change based on guidance from the Department for Medicaid Services. AKYPEC-2036-19 March 2019

Page 2 of 5 HIV RESCRIPTOR 200 MG TABLET RESCRIPTOR 100 MG TABLET CRIXIVAN 200 MG CAPSULE CRIXIVAN 400 MG CAPSULE KALETRA 100-25 MG TABLET KALETRA 200-50 MG TABLET VIDEX 2 GM PEDIATRIC SOLN VIDEX 4 GM PEDIATRIC SOLN VIRACEPT 250 MG TABLET VIRACEPT 625 MG TABLET COVERED ORAL STERIODS INJECTABLE STEROIDS PREDNISOLONE 10 MG/5 ML SOLN PREDNISOLONE 20 MG/5 ML SOLN PREDNISOLONE ODT 10 MG TABLET PREDNISOLONE ODT 15 MG TABLET PREDNISOLONE ODT 30 MG TABLET MILLIPRED DP 5 MG 6-DAY PACK MILLIPRED DP 5 MG 12-DAY PACK VERIPRED 20 20 MG/5 ML SOLN DECADRON 0.5 MG/5 ML ELIXIR DECADRON 0.5 MG TABLET DECADRON 0.75 MG TABLET DECADRON 4 MG TABLET DECADRON 6 MG TABLET DEXAMETHASONE 6 DAY 1.5 MG TAB DEXAMETHASONE 10 DAY 1.5 MG TB DEXAMETHASONE 13 DAY 1.5 MG TB DELTASONE 20 MG TABLET BETAMETHASONE AC-SP 6 MG/ML TRIAMCINOLONE ACET 50MG/5ML TRIAMCINOLONE ACET 40MG/ML METHYLPREDNISOLONE SS 40 MG METHYLPREDNISOLONE SS 125 MG METHYLPREDNISOLONE SS 1 GM DEXAMETHASONE 10 MG/50 ML-NS DEXAMETHASONE 10 MG/ML VIAL TRIAMCINOLONE ACET 40 MG/ML TRIAMCINOLONE 200 MG/5 ML VIAL TRIAMCINOLONE 400 MG/10 ML DEXAMETHASONE 4 MG/ML SYRINGE

Page 3 of 5 INJECTABLE STEROIDS * ANTIVIRALS SOLU-CORTEF 1;000 MG VIAL SOLU-CORTEF 100 MG VIAL SOLU-CORTEF 250 MG VIAL SOLU-CORTEF 500 MG VIAL XOFLUZA 20 MG TABLET XOFLUZA 40 MG TABLET NON- WITH QL 1 DOSE PACK PER FILL; 1 FILL PER 90 DAYS NO CHANGES IN /NON- STATUS REVISION OR ADDITION TO UM EDIT ONLY ADALIMUMAB HYRIMOZ 40 MG/0.8 ML PREFILLED PEN/SYRINGE 2 PENS/SYRINGES PER 28 DAYS ANTICONVULSANT DIACOMIT 250MG CAPS OR POWDER PACKETS; 12 PER DAY 500MG CAPSULES OR POWDER PACKETS; 6 PER DAY ANTIMALARIALS ARAKODA 100 MG TABLET 56 TABLETS PER YEAR ANTIMALARIALS KRINTAFEL 150 MG TABLET 2 TABLETS PER FILL; 1 FILL PER 30 DAYS ANTIMIGRAINE PREPARATIONS EMGALITY 120 MG/ML SYRINGE AND 1 SYRINGE PER 30 DAYS LUMOXITI 1 MG VIAL COPIKTRA 15 MG CAPSULE COPIKTRA 25 MG CAPSULE VIZIMPRO 15 MG TABLET VIZIMPRO 30 MG TABLET VIZIMPRO 45 MG TABLET LIBTAYO 350 MG/7 ML VIAL SIGNIFOR LAR 10 MG KIT SIGNIFOR LAR 30 MG KIT TIBSOVO 250 MG TABLET AND 2 PER DAY AND 1 KIT PER 28 DAYS

Page 4 of 5 NO CHANGES IN /NON- STATUS REVISION OR ADDITION TO UM EDIT ONLY LENVIMA 4 MG DAILY DOSE LENVIMA 12 MG DAILY DOSE 1 PACK PER 30 DAYS ANTIPARASITICS MOXIDECTIN 2 MG 4 TABLETS PER FILL; ONE TIME DOSE ANTIVERTIGO & CINVANTI 130 MG/18 ML VIAL ANTIEMETIC BOWEL EVACUANTS PLENVU POWDER PACKETS AND QL 1 KIT PER 30 DAYS COAGULATION TAVALISSE 100 MG TABLET TAVALISSE 150 MG TABLET AND CONTRACEPTIVES ANNOVERA 1 RING PER YEAR CONTRACEPTIVES BALCOLTRA TABLET DERMATOLOGICALS QBREXZA 2.4% CLOTH AND QL 1 CLOTH PER DAY DERMATOLOGICALS DUPIXENT 200 MG/1.14 ML SYRINGE 2 SYRINGES PER 28 DAYS HEMOPHILIA TREATMENT HEMLIBRA 60 MG/0.4 ML VIAL HEMLIBRA 105 MG/0.7 ML VIAL HEMLIBRA 30 MG/ML VIAL HEMLIBRA 150 MG/ML VIAL HEMOSTATICS DOPTELET 20 MG TAB AND QL 3 TABLETS PER DAY FOR 5 DAYS HEMOSTATICS MULPLETA 3 MG TABLET AND 1 TABLET PER DAY 7 DAYS INSULIN THERAPY NEUROLOGICAL THERAPY NOVOLIN R FLEXPEN NOVOLIN N FLEXPEN NOVOLIN 70-30 FLEXPEN TIGLUTIK 50 MG/10 ML SUSP PARSABIV 5 MG/ML VIAL PARSABIV 2.5 MG/0.5 ML VIAL PARSABIV 10 MG/2 ML VIAL TEGSEDI 284 MG/1.5 ML SYRINGE RELEXXII ER 72 MG TABLET JORNAY 20 PM CAPSULE JORNAY 40 PM CAPSULE JORNAY 60 PM CAPSULE JORNAY 80 PM CAPSULE JORNAY 100 PM CAPSULE 30 ML PER DAY AND QL 40 ML PER DAY AND 4 SYRINGES PER 28 DAYS AND QL 1 TABLET PER DAY AND QL 1 CAPSULES PER DAY

Page 5 of 5 NO CHANGES IN /NON- STATUS REVISION OR ADDITION TO UM EDIT ONLY PULMONARY RHEUMATOLOGICAL RHEUMATOLOGICAL * Implemented on January 15, 2019. PERSERIS ER INJECTABLE SUSPENSION TAKHZYRO 300 MG/2 ML VIAL OLUMIANT 2 MG TABLET XELJANZ 10 MG TABLET AND QL 1 KIT PER 30 DAYS AND 2 SYRINGES PER MONTH UPDATE PA AND What action do I need to take? Please review these changes and work with your Anthem patients to transition them to formulary. If you determine preferred formulary are not clinically appropriate for specific patients, you will need to obtain prior authorization to continue coverage beyond the applicable effective date. What if I need assistance? We recognize the unique aspects of patients cases. If for medical reasons your Anthem patient cannot be converted to a formulary alternative, call our Pharmacy department at 1-855-661-2028 and follow the voice prompts for pharmacy prior authorization. You can find the Preferred Drug List on our provider website at https://mediproviders.anthem.com/ky > Pharmacy. If you need assistance with any other item, contact your local Provider Relations representative or call Provider Services at 1-855-661-2028.